The erythropoietin drugs market was valued at $9,243.12 million in 2020, and is projected to reach $ 14,414.59 million by 2028, registering a CAGR of 5.7% from 2021 to 2028. Rise in number of patients ...

These factors typically result in a need for multiple blood transfusions. Because low plasma erythropoietin levels are present in anemia of prematurity, it has been theorized that enhancing ...

Routine administration of recombinant erythropoietin to patients on hemodialysis has greatly facilitated the management of chronic-kidney-disease-induced anemia. However, this glycoprotein hormone ...

Discover the commercial and brand names of the generic drug Erythropoietin. This indispensable guide is essential for healthcare professionals, patients, caregivers, and anyone seeking to ...

In patients with renal insufficiency associated with increased hemoglobin levels and polycythemia, the possibilities of recombinant erythropoietin overdosing and disorders such as neoplasms and ...